sleeping sickness

(redirected from African trypanosomiasis)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for sleeping sickness

an encephalitis that was epidemic between 1915 and 1926

References in periodicals archive ?
If the EMA decides to review the treatment, it would be the first all-oral treatment being investigated for Trypanosoma brucei gambiense human African trypanosomiasis (g-HAT).
Human African trypanosomiasis in endemic focus of Abraka, Nigeria.
The report provides a snapshot of the global therapeutic landscape of African Trypanosomiasis
Arsenicals (melarsoprol) pentamidine and suramin in the treatment of human African trypanosomiasis.
Washington, December 6 ( ANI ): Using the world's most powerful X-ray laser, an international team of scientists has revealed the three dimensional structure of a key enzyme that enables the single-celled parasite that causes African trypanosomiasis (or sleeping sickness) in humans.
African trypanosomiasis is a disease with many names--sleeping sickness, African lethargy--and is as iconic to the Dark Continent as Stanley and Livingstone.
Human African trypanosomiasis (HAT) cases are caused by the parasites Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense, which are indigenous to west and central Africa.
African Trypanosomiasis (sleeping sickness) is caused by Trypanosoma brucei, a hemoflagellate protozoan parasite, transmitted to human by an insect vector Tsetse fly (Glossina spp) found in some parts of rural Africa.
2) Five different approaches1 are proposed to tackle NDTs, intensive case management by early diagnosis and treatment is the approach used in leprosy but it is also the approach used for Buruli ulcer, Chagas disease, human African trypanosomiasis, leishmaniasis and yaws.
In African trypanosomiasis, cardiac manifestations are more prominent in Trypanosomiasis rhodesiense infection (Rhodesian sleeping sickness) than in T.
He is a world authority on infectious diseases of the nervous system, and his point is to inform non-scientists about the history and profound importance of human African trypanosomiasis, sleeping sickness, and its vector, the tsetse fly, which holds 60 million people hostage across the continent.
DFMO is already marketed in a topical formulation for the treatment of facial hirsutism, and as an injectable drug for treatment of African trypanosomiasis.
Human African Trypanosomiasis (HAT) is a major threat to approximately 60 million people living in 36 countries in sub-Saharan Africa.
African trypanosomiasis (sleeping sickness) is not frequently seen as an imported condition.
Full browser ?